BMS Bets up to $1.9 Billion on GentiBio’s Treg Platform for IBD
In partnership with GentiBio, BMS aims to harness the capabilities of engineered Treg therapies to re-establish immune tolerance and repair tissue in patients living with IBD.
The Home of the Life Sciences Industry
Langya Virus Outbreak Sounds Alarm as Monkeypox, COVID-19 Continue to Spread
Monkeypox is spreading, COVID-19 stubbornly persists and on Tuesday, news broke of a Langya henipavirus outbreak in China.
More Top Stories
- Cure Rare Disease Scores IND for First-in-Human CRISPR Therapeutic
- AstraZeneca, BMS Celebrate Cancer Trial Wins, Zebrafish Eye Mutatio...
- Billions in Debt and Buried in Opioid Lawsuits, Endo Eyes Bankruptcy
- MIT Makes Possible Breakthrough in Enabling Implantable Insulin Device
- Money on the Move: REVA Medical, Nanopath, Prellis and Others Grab ...
